Xiaodong Xie

4.2k citations
141 papers · 3.2k indexed · h-index 32
Topics
Cancer Cells and Metastasis (16 papers)Cancer, Hypoxia, and Metabolism (13 papers)RNA Interference and Gene Delivery (11 papers)

In The Last Decade

Xiaodong Xie

131 papers receiving 3.1k citations

Peers

Xiaodong Xie
Comparison fields: 5 of 135
  • Molecular Biology 1.7k
  • Oncology 625
  • Cancer Research 614
  • Biomedical Engineering 506
  • Immunology 465
Replace Yingqi Hua with:
Yingqi Hua China
Ann Y. Park United States
Ke Xu China
Ruifang Niu China
Tao Yi China
He Ren China
Zhengdong Cai China
Mohammad Hojjat‐Farsangi Sweden
Laurent Duca France
Hua Guo China
Xiaodong Xie relative to Yingqi Hua China Yingqi Hua's profile →
Citations per field
00.5×
Yingqi Hua · 1×
Citations per year

Countries citing papers authored by Xiaodong Xie

Since Specialization
Citations

This map shows the geographic impact of Xiaodong Xie's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaodong Xie with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaodong Xie more than expected).

Fields of papers citing papers by Xiaodong Xie

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiaodong Xie. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaodong Xie. The network helps show where Xiaodong Xie may publish in the future.

Co-authorship network of co-authors of Xiaodong Xie

This figure shows the co-authorship network connecting the top 25 collaborators of Xiaodong Xie. A scholar is included among the top collaborators of Xiaodong Xie based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiaodong Xie. Xiaodong Xie is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 2
2 0
3 9
4 9
5 2
6 6
7 12
8 8
9 10
10 57
11 4
12 10
13 87
14 0
15 18
16 10
17 4
18 2
19
Optimization of Agrobacterium-mediated transformation of sunflower (Helianthus annuus L.) immature embryos.
5
20 3

About Xiaodong Xie

Xiaodong Xie is a scholar working on Cancer Research, Oncology and Molecular Biology, having authored 141 papers that have together received 3.2k indexed citations. Recurring topics across this work include Cancer Cells and Metastasis (16 papers), Cancer, Hypoxia, and Metabolism (13 papers) and RNA Interference and Gene Delivery (11 papers). The work is most often cited by research in Cancer Research (614 citations), Biomaterials (375 citations) and Molecular Biology (1.7k citations). Xiaodong Xie has collaborated with scholars based in China, United States and United Kingdom. Frequent co-authors include Lee Jia, Yusheng Lu, Shu Lian, Yu Gao, Fengqiao Li, Huifang Nie, Mervin C. Yöder, Yunlong Cheng, Bifei Li and Hao Mei. Their work appears in journals such as Proceedings of the National Academy of Sciences, Journal of the American Chemical Society and Nucleic Acids Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026